CCDC110 | Coiled-coil domain containing 110 | | | | | | Tissue enriched |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCDC113 | Coiled-coil domain containing 113 | | | | | | Tissue enhanced |
CCDC15 | Coiled-coil domain containing 15 | | | | | | Tissue enhanced |
CCDC155 | Coiled-coil domain containing 155 | Predicted membrane proteins
| | | | | Tissue enriched |
CCDC181 | Coiled-coil domain containing 181 | | | | | | Tissue enhanced |
CCDC19 | Coiled-coil domain containing 19 | | | | | | Group enriched |
CCDC40 | Coiled-coil domain containing 40 | Disease related genes
| | | | | Tissue enhanced |
CCDC62 | Coiled-coil domain containing 62 | | | | | | Tissue enriched |
CCDC64 | Coiled-coil domain containing 64 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCHCR1 | Coiled-coil alpha-helical rod protein 1 | | | | | | Tissue enriched |
CCNB2 | Cyclin B2 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CCNB3 | Cyclin B3 | | | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CCNL1 | Cyclin L1 | Predicted secreted proteins
| | | | | Tissue enriched |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD79B | CD79b molecule, immunoglobulin-associated beta | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CDC20 | Cell division cycle 20 | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CDC25C | Cell division cycle 25C | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
CDC45 | Cell division cycle 45 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDCA2 | Cell division cycle associated 2 | | | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDH4 | Cadherin 4, type 1, R-cadherin (retinal) | Predicted membrane proteins
| | | | | Tissue enhanced |
CDK5R1 | Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | | | | | | Tissue enhanced |
CDKL5 | Cyclin-dependent kinase-like 5 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
CDKN3 | Cyclin-dependent kinase inhibitor 3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
CDT1 | Chromatin licensing and DNA replication factor 1 | Disease related genes
| | | | | Tissue enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CELSR1 | Cadherin, EGF LAG seven-pass G-type receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
CGB2 | Chorionic gonadotropin, beta polypeptide 2 | Predicted secreted proteins
| | | | | Tissue enriched |
CGB5 | Chorionic gonadotropin, beta polypeptide 5 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGB7 | Chorionic gonadotropin, beta polypeptide 7 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CGB8 | Chorionic gonadotropin, beta polypeptide 8 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CGNL1 | Cingulin-like 1 | Disease related genes
| | | | | Tissue enhanced |
CHAC1 | ChaC, cation transport regulator homolog 1 (E. coli) | | | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | | | | | | Tissue enhanced |
CLDN2 | Claudin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | | | Group enriched |
CMTM2 | CKLF-like MARVEL transmembrane domain containing 2 | Predicted membrane proteins
| | | | | Tissue enriched |
CNKSR1 | Connector enhancer of kinase suppressor of Ras 1 | Cancer-related genes
| | | | | Tissue enhanced |
CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase | Enzymes Plasma proteins
| | | | | Tissue enriched |
CNTN5 | Contactin 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COIL | Coilin | | | | | | Tissue enriched |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |